perfosfamide has been researched along with ATLL in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akutsu, M; Bai, L; Furukawa, Y; Ichikawa, A; Kano, Y; Kon, K; Suzuki, K; Tsunoda, S | 1 |
| Haake, R; Kersey, JH; Ledbetter, JA; Myers, DE; Ramsay, NK; Uckun, FM; Vallera, DA; Weisdorf, D | 1 |
1 trial(s) available for perfosfamide and ATLL
| Article | Year |
|---|---|
Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Separation; Child; Cyclophosphamide; Cytarabine; Female; Flow Cytometry; Fluorescent Antibody Technique; Hematopoietic Stem Cells; Humans; Immunophenotyping; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Male; Remission, Spontaneous; Transplantation, Autologous; Whole-Body Irradiation | 1990 |
1 other study(ies) available for perfosfamide and ATLL
| Article | Year |
|---|---|
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Neoplastic Stem Cells; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate; Vincristine | 2000 |